CeO2@CuS@PDA-FA as targeted near-infrared PTT/CDT therapeutic agents for cancer cells

Biomed Mater. 2023 Sep 15;18(6). doi: 10.1088/1748-605X/acf825.

Abstract

Single tumor treatment method usually has some defects, which makes it difficult to achieve good therapeutic effect. The ingenious combination of multiple tumor treatment methods on a single nanoplatform to achieve multifunctional treatment can effectively improve the efficiency of treatment. The targeted modification of nanomaterials can augment the precision of nanotherapeutic drugs in tumor treatment. Herein, a multifunctional nanoplatform (CeO2@CuS@PDA-FA) based on cerium dioxide nanoparticles engineered with copper sulfide (CeO2@CuS) has been constructed for synergistic photothermal therapy (PTT) and chemodynamic therapy (CDT). The CeO2@CuS were coated using polydopamine (PDA), and the modification of PDA surface by folic acid, in order to achieve the targeted effect for tumors. The localized hyperthermia induced by PTT can further improve the CDT efficiency of the nanoplatform, leading to a PTT/CDT synergistic effect. The nanoplatform possessed the capability of cancer cell-targeted and achieved better therapeutic efficacyin vitro. This work provided a new strategy for combined multifunctional theranostic platform and shows strong potential in practical applications.

Keywords: chemodynamic therapy; nanoplatform; photothermal therapy; tumor targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Electric Stimulation Therapy*
  • Indoles
  • Neoplasms* / drug therapy
  • Phototherapy
  • Photothermal Therapy

Substances

  • polydopamine
  • Indoles